The Pharmaceutical Supervision and Administration Bureau (ISAF) said in a statement on Thursday that two batches of Honpo Seirogan Pills under a licensed drug wholesaler, namely Leepharm Enterprises Limited, have been recalled from the local market due to potential quality issues.
The product, containing creosote, Phellodendron bark, sophora root and Citrus unshiu, is an over-the-counter medicine indicated for relief of occasional diarrhoea, the statement said, adding that the problematic product’s batch numbers are BAA9 and JAA9, manufactured by a Japanese manufacturer, Kyokuto Co. Ltd.
So far, the bureau has not received any adverse reaction reports in connection with the problematic batches of product. The bureau said it would closely monitor the recall.
According to Leepharm, the two batches have only been imported into Hong Kong since 2019 and supplied to local pharmacies, medicine stores and re-exported to Macau.
The statement stressed that the bureau is paying close attention to the matter, adding that residents who obtain the medicine from their neighbourhood pharmacies may consult their attending physician or pharmacist for “proper handling of the drug”.
Enquiries can be made by calling 8598 3533 during office hours.
This undated handout photo provided by the Pharmaceutical Supervision and Administration Bureau (ISAF) on Thursday shows the Japan-made diarrhoea relief medicine “Honpo Seirogan Pills”, produced by Kyokuto Co. Ltd.
